Ingenieurwissenschaften und zugeordnete Tätigkeiten
Filtern
Dokumenttyp
- Zeitschriftenartikel (8)
- Posterpräsentation (6)
- Vortrag (2)
Sprache
- Englisch (15)
- Mehrsprachig (1)
Schlagworte
- Polymorphism (16) (entfernen)
Organisationseinheit der BAM
Eingeladener Vortrag
- nein (2)
The lattice enthalpies and monotropic relationship of two dehydroepiandrosterone (DEHA) polymorphs (forms I and II) were evaluated through a combination of differential scanning calorimetry (DSC), isothermal solution microcalorimetry, and drop-sublimation Calvet microcalorimetry experiments. The standard molar enthalpy of transition between both forms was determined as ΔtrsHom (II→I, 298.15 K) = - 0.90 ± 0.07 kJ mol-1 and ΔtrsHom (II→I, 417.8 K) = - 1.7 ± 1.0 kJ mol- 1, from measurements of standard molar enthalpies of solution in dimethyl sulfoxide and enthalpies of fusion, respectively. Drop-sublimation Calvet microcalorimetry experiments on form I led to ΔsubHom (cr I, 298.15 K) = 132.0±3.3 kJ mol - 1. This result, when combined with the more precise ΔtrsHom (II→I) value obtained by solution calorimetry, afforded ΔsubHom (cr II, 298.15 K) = 131.1±3.3 kJ mol - 1. The overall data indicate that on enthalpic grounds form I is more stable than form II from 298.15 K up to fusion. This conclusion, and the fact that DSC experiments indicated that form I has also a considerably higher temperature fusion, namely, Tfus(cr I)= 422.5±0.2 K and Tfus(cr II) = 413.1±0.2 K, suggest that the two polymorphs are monotropically related.
Crystallization is a complex phenomenon with farreaching implications for the production and formulation of active pharmaceutical ingredients. Understanding this process is critical for achieving control over key physicochemical properties that can affect, for example, the bioavailability and stability of a drug. In this study, we were able to reveal intricate and diverse dynamics of the formation of metastable intermediates of paracetamol crystallization varying with the choice of solvent. We demonstrate the efficacy of our novel approach utilizing an objective function-based non-negative matrix factorization technique for the analysis of time-resolved Raman
spectroscopy data, in conjunction with time-lapse photography.
Furthermore, we emphasize the crucial importance of integrating Raman spectroscopy with supplementary experimental instrumentation for the mathematical analysis of the obtained spectra.
Mechanochemistry offers a unique opportunity to modify or synthesize new crystal forms. Although the method is very promising, little is known about the mechanochemical means to control the synthesis of a solid form. Using an polymorphic organic cocrystal system, we show here that mechanochemistry can be used to obtain a polymorph transformation under the apparently conventional (thermal) transition point.
Mechanochemistry offers a unique opportunity to modify and manipulate crystal forms, often providing new products as compared with conventional solution methods. While promising, there is little known about how to control the solid form through mechanochemical means, demanding dedicated investigations. Using a model organic cocrystal system (isonicotinamide:glutaric acid), we here demonstrate that with mechanochemistry, polymorphism can be induced in molecular solids under conditions seemingly different to their conventional thermodynamic (thermal) transition point. Whereas Form II converts to Form I upon heating to 363 K, the same transition can be initiated under ball milling conditions at markedly lower temperatures (348 K). Our results indicate that mechanochemical techniques can help to reduce the energy barriers to solid form transitions, offering new insights into controlling polymorphic forms. Moreover, our results suggest that the nature of mechanochemical transformations could make it difficult to interpret mechanochemical solid form landscapes using conventional equilibrium-based tools.
Molecular crystalline materials are usually brittle and are prone to breaking when mechanically stressed. This fragility greatly limits they application in next the generation of adaptable, functional materials. The recent discovery of mechanical compliancy in molecular crystals has solved this problem.1 Based on the nature of the deformation, molecular crystals can be divided into being plastically (irreversibly) or elastically (reversibly) bendable. The plastic deformation is generally associated with anisotropic molecular arrangements and the existence of low energy slip planes which allow a permanent motion within the lattice. Here we report 4-bromo-6-[(6-chloropyridin-2-ylimino)methyl]phenol (CPMBP) as a promising candidate for future waveguide technologies.2 CPMBP has been found to have two different polymorphs with distinct optical and mechanical properties. The brittle crystals of Form I exhibits very weak emission at 605 nm (λex = 425 nm; photoluminescence quantum yield Φ = 0.4 %). In contrast, Form II has a large plastic regime together with a bright emission at 585 nm (λex = 425 nm; Φ = 8.7 %). Taking advantage of the favorable mechanical flexibility and optical properties, Form II was used as a shapeable optical waveguide. By changing the wavelength of the light source, active or passive waveguiding can be realized. CPMBP could thus be used as a flexible wavelength filter.
Molecular crystalline materials are usually brittle and are prone to breaking when mechanically stressed. This fragility greatly limits they application in next the generation of adaptable, functional materials. The recent discovery of mechanical compliancy in molecular crystals has solved this problem.1 Based on the nature of the deformation, molecular crystals can be divided into being plastically (irreversibly) or elastically (reversibly) bendable. The plastic deformation is generally associated with anisotropic molecular arrangements and the existence of low energy slip planes which allow a permanent motion within the lattice. Here we report 4-bromo-6-[(6-chloropyridin-2-ylimino)methyl]phenol (CPMBP) as a promising candidate for future waveguide technologies.2 CPMBP has been found to have two different polymorphs with distinct optical and mechanical properties. The brittle crystals of Form I exhibits very weak emission at 605 nm (λex = 425 nm; photoluminescence quantum yield Φ = 0.4 %). In contrast, Form II has a large plastic regime together with a bright emission at 585 nm (λex = 425 nm; Φ = 8.7 %). Taking advantage of the favorable mechanical flexibility and optical properties, Form II was used as a shapeable optical waveguide. By changing the wavelength of the light source, active or passive waveguiding can be realized. CPMBP could thus be used as a flexible wavelength filter.
Kristalle sind in der Regel spröde und neigen dazu, bei mechanischer Belastung zu brechen. Dieses Verhalten schränkt ihre Anwendungsmöglichkeiten stark ein. Durch die Entdeckung von mechanischer Flexibilität in Kristallen wurde dieses Problem gelöst. Je nach Art der Verformung können Kristalle in plastisch (irreversibel) oder elastisch (reversibel) biegbar unterteilt werden. Die Verbindung 4-Brom-6-[(6-chlorpyridin-2-ylimino)methyl]phenol (BCMPMP) ist ein vielversprechender Kandidat für die Anwendung als flexibler Waveguide. BCMPMP hat zwei verschiedene Polymorphe mit unterschiedlichen optischen und mechanischen Eigenschaften. Die spröden Kristalle der Form I zeigen eine sehr schwache Emission bei 605 nm (λex = 425 nm; Photolumineszenz-Quantenausbeute Φ = 0,4 %). Im Gegensatz dazu zeigt die plastische Form II eine starke Emission bei 585 nm (λex = 425 nm; Φ = 8,7 %). Aufgrund der mechanischen Flexibilität wurde die Eignung der Form II als Waveguide untersucht.
Crystalline molecular materials are usually brittle and are prone to break upon external mechanical force. This fragility poses challenges for their application in next-generation technologies, including sensors, synthetic tissues, and advanced opto-electronics. The recent discovery of mechanical flexibility in single crystals of molecular materials has solved this problem and enable the design of smart flexible device technologies. Mechanical flexibility of organic crystals can be tuned by altering the weak interactions in the crystal structure, for examples through polymorphism. Here we report 4-bromo-6-[(6-chlorolpyridin-2-ylimino)methyl]phenol (BCMPMP) as a promising candidate for future waveguide technologies. It turns out that BCMPMP has two different polymorphs with distinct optical and mechanical properties. Form I shows brittle behavior under mechanical stress and exhibits very weak emission at 605 nm (λex = 425 nm) together with a low fluorescence quantum yield (Φ = 0.4 %).In contrast, Form II has a large plastic (irreversible bending) regime and a bright emission at 585 nm (λex = 425 nm; Φ = 8.7 %). Making use of favorable mechanical fexiblity and optical properties, form II was explored as a bendable optical waveguide. Light was successfully propagated through a straight-shaped and mechanically deformed BCMPMP crystal. Depending on the light source, active or passive waveguiding could be achieved. So BCMPMP can also be used as a flexible wavelength filter.
Crystalline molecular materials are usually brittle and are prone to break into pieces upon external mechanical force. This fragility poses challenges for their application in next-generation technologies, including sensors, synthetic tissues, and advanced opto-electronics. The recent discovery of mechanical flexibility in single crystals of molecular materials has solved this issue and enable the design of smart flexible device technologies. Plastic crystals can be deformed permanently. This behavior is based on anisotropic molecular arrangements and the existence of facile slip planes which allow a permanent motion within the lattice. In contrast, elastic crystals can be deformed, but regain the original structure when the force is removed. This phenomenon is related to energetically isotropic molecular packing. Here we report 4-bromo-6-[(6-chlorolpyridin-2-ylimino)methyl]phenol (BCMPMP) as a promising candidate for future waveguide technologies. It turns out that BCMPMP has two different polymorphs with distinct optical and mechanical properties. Form I crystallizes in the orthorhombic space group Pca21 and shows brittle behavior. This structure exhibit very weak emission at 605 nm (λex = 425 nm) together with a low fluorescence quantum yield (Φ = 0.4 %). On the other hand, form II (monoclinic space group P21/c) has a large plastic regime and a bright emission at 585 nm (λex = 425 nm; Φ = 8.7 %). Based on its improved mechanical and optical properties, form II was explored as a bendable optical waveguide. Light was successfully propagated through a straight-shaped and mechanically deformed BCMPMP crystal. Depending on the light source, active or passive waveguiding could be achieved. So BCMPMP can also be used as a flexible wavelength filter.
The choice of solvents influences crystalline solid formed during the crystallization of active pharmaceutical ingredients (API). The underlying effects are not always well understood because of the complexity of the systems. Theoretical models are often insufficient to describe this phenomenon. In this study, the crystallization behavior of the model drug paracetamol in different solvents was studied based on experimental and molecular dynamics data. The crystallization process was followed in situ using time-resolved Raman spectroscopy. Molecular dynamics with simulated annealing algorithm was used for an atomistic understanding of the underlying processes. The experimental and theoretical data indicate that paracetamol molecules adopt a particular geometry in a given solvent predefining the crystallization of certain polymorphs
: Simvastatin is one of the most widely used active pharmaceutical ingredients for the treatment of hyperlipidemias. Because the compound is employed as a solid in drug formulations, particular attention should be given to the characterization of different polymorphs, their stability domains, and the nature of the phase transitions that relate them. In this work, the phase transitions delimiting the stability domains of three previously reported simvastatin forms were investigated from structural, energetics, and dynamical points of view based on single crystal X-ray diffraction (SCXRD), hot stage microscopy (HSM), and differential scanning calorimetry (DSC) experiments (conventional scans and heat capacity measurements), complemented with molecular dynamics (MD) simulations. Previous assignments of the crystal forms were confirmed by SCXRD: forms I and II were found to be orthorhombic (P212121, Z′/Z = 1/4) and form III was monoclinic (P21, Z′/Z = 2/4). The obtained results further indicated that (i) the transitions between different forms are observed at 235.9 ± 0.1 K (form III → form II) and at 275.2 ± 0.2 K (form II → form I) in DSC runs carried out at 10 K min−1 and close to these values when other types of techniques are used (e.g., HSM). (ii) They are enantiotropic (i.e., there is a transition temperature relating the two phases before fusion at which the stability order is reversed), fast, reversible, with very little hysteresis between heating and cooling modes, and occur under single crystal to single crystal conditions. (iii) A nucleation and growth mechanism seems to be followed since HSM experiments on single crystals evidenced the propagation of an interface, accompanied by a change of birefringence and crystal contraction or expansion (more subtle in the case of form III → form II), when the phase transitions are triggered. (iv) Consistent with the reversible and small hysteresis nature of the phase transitions, the SCXRD results indicated that the molecular packing is very similar in all forms and the main structural differences are associated with conformational changes of the “ester tail”. (v) The MD simulations further suggested that the tail is essentially “frozen” in two conformations below the III → II transition temperature, becomes progressively less hindered throughout the stability domain of form II, and acquires a large conformational freedom above the II → I transition. Finally, the fact that these transitions were found to be fast and reversible suggests that polymorphism is unlikely to be a problem for pharmaceutical formulations employing crystalline simvastatin because, if present, the III and II forms will readily convert to form I at ambient temperature.
Simvastatin is a prominent member of the statin family, a class of antilipidemic drugs widely used in the treatment of high plasma cholesterol levels, and thus in the prevention of atherosclerosis and cardiovascular diseases. Simvastatin is typically employed as a solid and it is well known that, in this case, the detection and characterization of polymorphism is of considerable importance. Polymorphs differ by their packing arrangements and also, occasionally, by the conformations of the molecules in the crystal lattice. These structural variations are normally reflected by differences in physical properties, such as solubility and dissolution rate in a given media, which may significantly affect the bioavailability of a drug. The lack of control of polymorphism can, therefore, play havoc with the safe use of a drug.
Theoretical and experimental studies indicate that crystal nucleation can take more complex pathways than expected on the ground of the classical nucleation theory. A direct in situ observation of the different pathways of nucleation from solution is challenging since the paths can be influenced by heterogeneous nucleation sites, such as container walls.
The custom-made acoustic levitator using in these experiments regulates the influence that solid surfaces, temperature, and humidity have on the crystallization process. The investigations of the crystallization process of paracetamol were performed with in situ analytical techniques and theoretical simulations to gain a comprehensive insight into processes, occurring intermediates, and required reaction conditions. The targeted choice of the solvent and the concentration enabled the guidance of the pathways, therefore, resulting in the isolation of one desired crystalline structure.
Particularly relevant in the context of polymorphism is understanding how structural, thermodynamic, and kinetic factors dictate the stability domains of polymorphs, their tendency to interconvert through phase transitions, or their possibility to exist in metastable states. These three aspects were investigated here for two 4′-hydroxyacetophenone (HAP) polymorphs, differing in crystal system, space group, and number and conformation of molecules in the asymmetric unit. The results led to a ΔfGm°-T phase diagram highlighting the enantiotropic nature of the system and the fact that the Z′=1 polymorph is not necessarily more stable than its Z′=2 counterpart. It was also shown that the form II → form I transition is entropy driven and is likely to occur through a nucleation and growth mechanism, which does not involve intermediate phases, and is characterized by a high activation energy. Finally, although it has been noted that conflicts between hydrogen bond formation and close packing are usually behind exceptions from the hypothesis of Z′=1 forms being more stable than their higher Z′ analogues, in this case, the HAP polymorph with stronger hydrogen bonds (Z′=2) is also the one with higher density.
Control of organic polymorph formation: crystallization pathways in acoustically levitated droplets
(2017)
Theoretical and experimental studies indicate that crystal nucleation can take more complex pathways than expected on the ground of the classical nucleation theory. Among these pathways are the formation of pre-nucleation clusters and amorphous precursor phases. A direct in situ observation of the different pathways of nucleation from solution is challenging since the paths can be influenced by heterogeneous nucleation sites, such as container walls. Here, we provide insights into the crystallization process using the in situ combination of an acoustic levitator, Raman spectroscopy, and X-ray scattering. The contactless sample holder enables the observation of homogeneous crystallization processes and the detection of intermediates and final crystalline forms. We provide evidence for the existence of multiple pathways of nucleation based on the investigation of the crystallization of organic molecules from different solvents. Starting from a diluted solution, a supersaturation is reached during the experiment due to the evaporation of the solvent. The highly supersaturated solution reveals different pathways of crystallization. Depending on the degree of supersaturation either the thermodynamically stable or the metastable crystal form is observed.
The transformation of amorphous precursors into crystalline solids and the associated mechanisms are still poorly understood. We illuminate the formation and reactivity of an amorphous cobalt phosphate hydrate precursor and the role of water for its crystallization process. Amorphous cobalt phosphate hydrate nanoparticles (ACP) with diameters of ∼20 nm were prepared in the absence of additives from aqueous solutions at low concentrations and with short reaction times. To avoid the kinetically controlled transformation of metastable ACP into crystalline Co₃(PO₄)₂ × 8H₂O (CPO) its separation must be fast. The crystallinity of ACP could be controlled through the temperature during precipitation. A second amorphous phase (HT-ACP) containing less water and anhydrous Co₃(PO₄)₂ was formed at higher temperature by the release of coordinating water. ACP contains approximately five molecules of structural water per formula unit as determined by thermal analysis (TGA) and quantitative IR spectroscopy. The Co²+ coordination in ACP is tetrahedral, as shown by XANES/EXAFS spectroscopy, but octahedral in crystalline CPO. ACP is stable in the absence of water even at 500 °C. In the wet state, the transformation of ACP to CPO is triggered by the diffusion and incorporation of water into the structure. Quantitative in situ IR analysis allowed monitoring the crystallization kinetics of ACP in the presence of water.